Aligos Therapeutics (ALGS) EPS (Basic) (2021 - 2025)
Historic EPS (Basic) for Aligos Therapeutics (ALGS) over the last 5 years, with Q3 2025 value amounting to -$3.04.
- Aligos Therapeutics' EPS (Basic) rose 97.72% to -$3.04 in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.55, marking a year-over-year decrease of 6845.64%. This contributed to the annual value of -$20.94 for FY2024, which is 3875.79% up from last year.
- According to the latest figures from Q3 2025, Aligos Therapeutics' EPS (Basic) is -$3.04, which was up 97.72% from -$1.53 recorded in Q2 2025.
- In the past 5 years, Aligos Therapeutics' EPS (Basic) registered a high of $5.12 during Q1 2025, and its lowest value of -$13.11 during Q4 2024.
- In the last 5 years, Aligos Therapeutics' EPS (Basic) had a median value of -$0.78 in 2021 and averaged -$1.94.
- The largest annual percentage gain for Aligos Therapeutics' EPS (Basic) in the last 5 years was 28837.21% (2024), contrasted with its biggest fall of 346239.54% (2024).
- Over the past 5 years, Aligos Therapeutics' EPS (Basic) (Quarter) stood at -$0.91 in 2021, then surged by 43.96% to -$0.51 in 2022, then surged by 176.47% to $0.39 in 2023, then crashed by 3462.4% to -$13.11 in 2024, then skyrocketed by 76.82% to -$3.04 in 2025.
- Its last three reported values are -$3.04 in Q3 2025, -$1.53 for Q2 2025, and $5.12 during Q1 2025.